Medicine and Dentistry
Heart Failure
92%
Randomized Controlled Trial
64%
Heart Arrest
60%
Atrial Fibrillation
60%
Coronary Artery Disease
60%
Telerehabilitation
58%
Positron Emission Tomography
49%
Placebo
40%
Coronary Angiography
40%
Systematic Review
34%
Return of Spontaneous Circulation
34%
Meta-Analysis
34%
Quality of Life
33%
Myocardial Perfusion Imaging
31%
Myocardial Infarction
31%
Rehabilitation Engineering
31%
Prevalence
30%
ST Segment Elevation Myocardial Infarction
27%
Positron Emission Tomography
26%
Screening
26%
Symptom
25%
Diagnostic Performance
25%
Diabetes Mellitus
25%
Fractional Flow Reserve
25%
Disease
25%
Heart Muscle Perfusion
25%
Multiple Myeloma
25%
Noncardiac Surgery
25%
General Anesthesia
25%
Cardiogenic Shock
25%
Heart Rehabilitation
24%
Stenosis
23%
Cardiovascular System
21%
Drug Therapy
21%
Heart Muscle Blood Flow
21%
Cardiac Magnetic Resonance Imaging
21%
Blood Pressure
21%
Hazard Ratio
20%
Cardiovascular Disease
20%
Randomized Clinical Trial
20%
Cardiac Dysrhythmia
19%
Odds Ratio
19%
Hyperaemia
18%
Cohort Analysis
18%
Percutaneous Coronary Intervention
17%
Coronary Artery Obstruction
17%
Acute Heart Infarction
17%
Out of Hospital Cardiac Arrest
16%
Cardiovascular Risk
16%
Patient-Reported Outcome
16%
Pulmonary Embolism
16%
Amlodipine
16%
Metoprolol
16%
Hypertrophic Cardiomyopathy
16%
Mass Screening
16%
Angiography
16%
Shared Care
16%
Oxygen 15
16%
Radioactive Tracer
16%
Cardioversion
16%
Thorax Pain
15%
Non ST Segment Elevation Myocardial Infarction
15%
Attributable Risk
15%
Rapamycin
13%
Glyceryl Trinitrate
13%
Arm
13%
Acute Coronary Syndrome
13%
Coronary Computed Tomography Angiography
13%
Diagnosis
13%
Resuscitation
12%
Cardiovascular Condition
12%
Diagnostic Accuracy
12%
Revascularization
12%
Health Care Cost
11%
Triage
11%
All Cause Mortality
11%
Outpatient
11%
Chronic Obstructive Pulmonary Disease
11%
Hemodynamic
11%
Remote Sensing
10%
General Practitioner
10%
Health Care
10%
Exercise
10%
Electrocardiogram
10%
Abdominal Aortic Aneurysm
10%
Defibrillator
10%
Maturity Onset Diabetes of the Young
10%
Thermodilution
10%
Observational Study
10%
Heart Failure with Reduced Ejection Fraction
9%
Computer Assisted Tomography
9%
Cost-Effectiveness Analysis
9%
Vericiguat
9%
COVID-19
9%
Sex Difference
9%
Heart Muscle Ischemia
9%
Subgroup Analysis
9%
Apoplexy
9%
Arteriosclerosis Obliterans
9%
Primary Percutaneous Coronary Intervention
9%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Placebo
63%
Coronary Artery Disease
52%
Heart Arrest
50%
Heart Infarction
50%
All Cause Mortality
38%
Diabetes Mellitus
35%
Acetylsalicylic Acid
34%
Heart Failure with Reduced Ejection Fraction
27%
Vericiguat
26%
Rivaroxaban
25%
Bleeding
22%
Sacubitril Plus Valsartan
20%
Atrial Fibrillation
19%
Acute Coronary Syndrome
19%
ST Segment Elevation Myocardial Infarction
18%
Non Insulin Dependent Diabetes Mellitus
18%
Cardiovascular Disease
18%
Coronary Artery Obstruction
17%
Malignant Neoplasm
17%
Ticagrelor
16%
Heart Arrhythmia
16%
Acute Heart Infarction
16%
Polyunsaturated Fatty Acid
16%
Cardiogenic Shock
16%
Symptom
16%
Disease
16%
Enalapril
13%
Peripheral Occlusive Artery Disease
12%
Hemoglobin A1c
12%
Cardiovascular Risk
11%
Adenosine
10%
Chronic Obstructive Lung Disease
9%
Heart Muscle Ischemia
9%
Overall Survival
9%
Randomized Clinical Trial
9%
Membrane Metalloendopeptidase
9%
Beta Adrenergic Receptor Blocking Agent
9%
Observational Study
9%
Guanylate Cyclase
8%
Guanylate Cyclase Activator
8%
Randomized Controlled Trial
8%
Lipoprotein A
8%
D Dimer
8%
Resistant Hypertension
8%
Dicarbonate
8%
Dyspnea
8%
Carotid Artery Disease
8%
Impaired Glucose Tolerance
8%
Vasopressin
8%
Isosorbide Dinitrate
8%
Lung Embolism
8%
Methylprednisolone
8%
Captopril
8%
Nitric Oxide
8%
Angiotensin
8%
Antithrombotic Therapy
8%
Lidocaine
8%
Troponin
8%
Copeptin
8%
Everolimus
8%
Drug Administration
8%
Familial Hypercholesterolemia
8%
Ubiquinol
8%
Ubidecarenone
8%
Postoperative Complication
8%
Multiple Myeloma
8%
Heart Ventricle Remodeling
8%
Glyceryl Trinitrate
8%
Inflammation
8%
Essential Hypertension
8%
Inotropic Agent
8%
Omega-3 Fatty Acid
8%
Hemodialysis
8%
Prospective Cohort Study
8%
Neoplasm
8%
Hospital Mortality
7%
Thorax Pain
7%
Stenosis
7%
Clinical Trial
6%
Non ST Segment Elevation Myocardial Infarction
6%
Prevalence
6%
Anastomosis Leakage
5%
Rapamycin
5%
Congestive Heart Failure
5%
Deterioration
5%
Nursing and Health Professions
Heart Failure
66%
Telerehabilitation
50%
Coronary Artery Disease
46%
Systematic Review
34%
Quality of Life
34%
Meta Analysis
34%
Rehabilitation Engineering
25%
Multiple Myeloma
25%
General Anesthesia
25%
Atrial Fibrillation
25%
Heart Rehabilitation
24%
Symptom
22%
Disease
20%
Patient-Reported Outcome
18%
Heart Arrest
18%
Shared Care
16%
Polyethylene Terephthalate
16%
Heart Muscle Blood Flow
16%
Lung Embolism
16%
Practice Guideline
16%
Perfusion
15%
Outpatient
15%
Diagnosis
15%
Coronary Angiography
14%
Confidence Interval
14%
Tidal Volume
14%
Resuscitation
12%
Length of Stay
12%
Health Care Personnel
12%
Hospital Discharge
11%
Odds Ratio
11%
Heart Infarction
10%
Diagnostic Accuracy
10%
Coronary Artery Obstruction
10%
Fractional Flow Reserve
10%
Pilot Study
9%
Heart Muscle Ischemia
9%
Acute Coronary Syndrome
9%
Cardiovascular Magnetic Resonance
9%
General Practice
9%
Health Care Utilization
9%
Cost Utility Analysis
9%
Medline
8%
Health Care Cost
8%
Placebo
8%
Transitional Care
8%
Heart Ventricle Remodeling
8%
Inflammation
8%
Cholesterol Blood Level
8%
Dyspnea
8%
Obstructive Lung Disease
8%
Anticoagulant Therapy
8%
Myeloma
8%
Heart Surgery
8%
Rivaroxaban
8%
Fraction of Inspired Oxygen
8%
Content Validity
8%
Cardioversion
8%
D Dimer
8%
Telehealth
8%
Beta Adrenergic Receptor Blocking Agent
8%
Mass Screening
8%
Malignant Neoplasm
8%
Carvedilol
8%
Patient with Congestive Heart Failure
8%
Nuclear Magnetic Resonance
8%
Cost Effectiveness Analysis
8%
Cardiogenic Shock
8%
Computed Tomographic Angiography
8%
Thorax Pain
7%
Embase
7%
Compliance
6%
Stenosis
6%
Postoperative Complication
6%
Continuous Positive Airway Pressure
6%
General Practitioner
5%
Hospital
5%
Prevalence
5%
Hospital Mortality
5%
Pediatric Advanced Life Support
5%
Logistic Regression Analysis
5%
Positron Emission Tomography
5%
Pain Intensity
5%
Deterioration
5%
Personalized Medicine
5%